글로벌 연구동향
핵의학
- 2021년 01월호
[Clin Nucl Med.] Clinical and Striatal Dopamine Transporter Predictors of Mild Behavioral Impairment in Drug-Naive Parkinson Disease연세의대 / 유한수, 윤미진*, 이필휴*
- 출처
- Clin Nucl Med.
- 등재일
- 2020 Nov
- 저널이슈번호
- 45(11):e463-e468. doi: 10.1097/RLU.0000000000003281.
- 내용
Abstract
Purpose: Neuropsychiatric symptoms are important and frequent nonmotor features in Parkinson disease (PD). We explored mild behavioral impairment (MBI) in drug-naive patients with PD and its clinical and dopamine transporter (DAT) correlates.Methods: We recruited 275 drug-naive patients with PD who had undergone Unified Parkinson's Disease Rating Scale, a neuropsychological battery, Neuropsychiatric Inventory, and N-(3-[F]fluoropropyl)-2β-carbon ethoxy-3β-(4-iodophenyl) PET within 6 months. Patients with PD were divided into groups without MBI (PD-MBI-, n = 186) and with MBI (PD-MBI+, n = 89) according to the Neuropsychiatric Inventory. We performed comparative analysis of DAT availability, cognitive function, and motor deficits between the groups.
Results: Mild behavioral impairment was found in 32.4% of PD patients at the time of diagnosis, and affective dysregulation and decreased motivation were the 2 most common neuropsychiatric domains. Dopamine transporter availability in the anterior caudate (odds ratio, 0.60; P = 0.016) and anterior putamen (odds ratio, 0.58; P = 0.008) was associated with the development of MBI in PD. PD-MBI+ group had a lower z-score in memory-related tests and Stroop color reading test than PD-MBI- group. PD-MBI+ group had a higher Unified Parkinson's Disease Rating Scale motor score after controlling for DAT availability in the posterior putamen than PD-MBI- group (P = 0.007).
Conclusions: This study suggests that early behavioral impairment is associated with more pathological involvement in the anterior striatum, memory and frontal dysfunction, and motor deficits, which could be regarded as a different phenotype in PD.
Affiliations
Han Soo Yoo 1 , Sangwon Lee 2 , Seok Jong Chung 3 , Byoung Seok Ye 1 , Young H Sohn 1 , Mijin Yun 2 , Phil Hyu Lee 1 4
1 From the Departments of Neurology.
2 Nuclear Medicine, Yonsei University College of Medicine, Seoul.
3 Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin.
4 Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
- 덧글달기
- 이전글 [Eur J Nucl Med Mol Imaging.] Temporal trajectories of in vivo tau and amyloid-β accumulation in Alzheimer's disease
- 다음글 [Clin Nucl Med.] Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351